SCHEMBL28973261

SCHEMBL28973261

CC(=O)Oc1ccc(CSCc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.56
GAA P10253 2/20 0.55
MAPT P10636 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HSP90AA1 P07900 1/20 0.53
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
LMNA P02545 3/20 0.51
HTT P42858 2/20 0.51
KMT2A Q03164 3/20 0.48
POLB P06746 2/20 0.48
HSD17B10 Q99714 2/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.47
KDM4E B2RXH2 2/20 0.47
PTGS2 P35354 2/20 0.45
MEN1 O00255 1/20 0.45
PKM P14618 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29211133 0.94 GAA (0.50) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL6031811 0.93 LMNA (0.55) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL1127804 0.87 RAB9A (0.49) ELANEGAAMAPTALDH1A1RAB9A
SCHEMBL28687523 0.86 LMNA (0.51) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL29154508 0.85 ELANE (0.55) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL29154507 0.85 ELANE (0.55) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL9220921 0.84 LMNA (0.49) MAPTALDH1A1RAB9ASMN1; SMN2LMNA
SCHEMBL531085 0.84 ELANE (0.61) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL717987 0.84 NPC1 (0.65) ELANEGAAMAPTALDH1A1HSP90AA1
SCHEMBL28687524 0.84 KDM4E (0.44) ELANEGAAMAPTALDH1A1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600881-B2 Composition for forming hard coating layer, hard coating layer using the composition, and laminate comprising the hard coating layer DONGJIN SEMICHEM CO., LTD. (KR) 2026-04-14 US disclosed
US-20260086276-A1 OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2026-03-26 US disclosed
US-20250346813-A1 PHOTO-ALIGNMENT FILM, OPTICAL FILM, CIRCULARLY POLARIZING PLATE, IMAGE DISPLAY APPARATUS, AND METHOD FOR MANUFACTURING CIRCULARLY POLARIZING PLATE FUJIFILM CORPORATION (JP) 2025-11-13 US disclosed
CN-115836100-A Polymerizable composition, cured product, and method for producing cured product 株式会社艾迪科 2023-03-21 CN disclosed
WO-2022092080-A1 POLYMERIZABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT 株式会社ADEKA 2022-05-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260086276-A1 OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE CLTB, CDH1, PTK2 ELANE 3489/4885GAA 3844/4885MAPT 617/4885
US-12600881-B2 Composition for forming hard coating layer, hard coating layer using the composition, and laminate comprising the hard coating layer TAF5, TAF1, ITGB7 ELANE 4023/4885GAA 2820/4885MAPT 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.